Edition:
India

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.41USD
1:30am IST
Change (% chg)

$-0.01 (-2.21%)
Prev Close
$0.42
Open
$0.43
Day's High
$0.44
Day's Low
$0.41
Volume
187,749
Avg. Vol
28,706
52-wk High
$3.92
52-wk Low
$0.39

Latest Key Developments (Source: Significant Developments)

Akers Biosciences Reports Q2 2019 Earnings
Thursday, 15 Aug 2019 

Aug 15 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES REPORTS Q2 2019 EARNINGS.AKERS BIOSCIENCES INC - AT JUNE 30, 2019, CO HAD CASH, RESTRICTED CASH AND MARKETABLE SECURITIES OF $4.39 MILLION.AKERS BIOSCIENCES INC - DIRECTORS' PROCESS REMAINS UNDERWAY TO EVALUATE STRATEGIC ALTERNATIVES.AKERS BIOSCIENCES INC - BOARD HAS BEEN AND WILL CONTINUE TO CONSIDER A RANGE OF POTENTIAL STRATEGIC ALTERNATIVES.  Full Article

Akers Biosciences Announces Restoration Of Trading On AIM Market Of LSE
Friday, 16 Nov 2018 

Nov 16 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES - REVERSE STOCK SPLIT UPDATE.AKERS BIOSCIENCES INC - RESTORATION OF TRADING ON AIM MARKET OF LONDON STOCK EXCHANGE.AKERS BIOSCIENCES - WORKSTREAMS REQUIRED FOR ADMISSION TO AIM MARKET CO'S SHARES AS A RESULT OF REVERSE STOCK SPLIT HAVE NOW BEEN COMPLETED.  Full Article

Akers Biosciences announces Q3 earnings
Thursday, 15 Nov 2018 

Nov 15 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES ANNOUNCES Q3 2018 EARNINGS.Q3 REVENUE FELL 18 PERCENT TO $557,100.COMPANY CONTINUING TO EVALUATE STRATEGIC ALTERNATIVES TO MAXIMIZE SHAREHOLDER VALUE.  Full Article

Akers Biosciences Files Restated Previously Issued Financial Statements For 2017
Saturday, 14 Jul 2018 

Akers Biosciences Inc ::AKERS BIOSCIENCES FILES RESTATED PREVIOUSLY ISSUED FINANCIAL STATEMENTS FOR 2017.AKERS BIOSCIENCES - FILED RESTATEMENTS OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS FOR QUARTERLY PERIODS ENDED JUNE 30, SEPT 30, 2017 AND FOR FY ENDED DEC 31, 2017.  Full Article

Akers Biosciences Confirms Receiving Class Action
Thursday, 21 Jun 2018 

June 21 (Reuters) - Akers Biosciences Inc ::CONFIRMS IT HAS RECEIVED A CLASS ACTION AGAINST CO; CLASS ACTION RELATES TO PERIOD MAY 15, 2017 TO JUNE 5, 2018.  Full Article

Akers Biosciences Says Terminated Raymond Akers Positions As Executive Chairman
Thursday, 26 Apr 2018 

April 26 (Reuters) - Akers Biosciences Inc ::SAYS TERMINATED RAYMOND AKERS POSITIONS AS EXECUTIVE CHAIRMAN, CHIEF SCIENTIFIC DIRECTOR AND SECRETARY OF COMPANY.SAYS APPOINTED RICHARD CARLYLE TARBOX III AS INTERIM NON-EXECUTIVE CHAIRMAN.  Full Article

Akers Biosciences Expands Outsourced U.S. Distribution Capabilities For Heparin PF4 Rapid Test
Thursday, 12 Apr 2018 

April 12 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES EXPANDS OUTSOURCED US DISTRIBUTION CAPABILITIES FOR HEPARIN PF4 RAPID TEST.AKERS BIOSCIENCES INC - AGREEMENTS WITH OPTO-SYSTEMS AND HERZOG SURGICAL TO INCREASE U.S. SALES FOR RAPID TEST.  Full Article

Akers Biosciences Reports Earnings For Fiscal Year 2017
Tuesday, 3 Apr 2018 

April 3 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES REPORTS EARNINGS FOR FISCAL YEAR 2017.  Full Article

Akers Biosciences Files For Non Timely 10-K SEC Filing‍
Tuesday, 3 Apr 2018 

April 3 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES FILES FOR NON TIMELY 10-K - SEC FILING‍.  Full Article

Akers Biosciences Announces Distribution Agreement With Diagnostica Stago​
Monday, 26 Mar 2018 

March 26 (Reuters) - Akers Biosciences Inc ::‍DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO​.‍ENTERED INTO 3-YEAR DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO FOR SALE OF CO'S RAPID TEST FOR HEPARIN-INDUCED THROMBOCYTOPENIA ACROSS US​.  Full Article